IL-33 blockade prevents exacerbations in a model of chronic airway inflammation by blunting persistent inflammation and remodeling

J. Allinne (Tarrytown, United States of America), W. Lim (Tarrytown, United States of America), G. Scott (Tarrytown, United States of America), C. Sandén (Lund, Sweden), J. Erjefält (Lund, Sweden), D. Birchard (Tarrytown, United States of America), L. Ben (Tarrytown, United States of America), A. Murphy (Tarrytown, United States of America), M. Sleeman (Tarrytown, United States of America), J. Orengo (Tarrytown, United States of America)

Source: International Congress 2019 – Advances in asthma pharmacology
Session: Advances in asthma pharmacology
Session type: Poster Discussion
Number: 3876
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Allinne (Tarrytown, United States of America), W. Lim (Tarrytown, United States of America), G. Scott (Tarrytown, United States of America), C. Sandén (Lund, Sweden), J. Erjefält (Lund, Sweden), D. Birchard (Tarrytown, United States of America), L. Ben (Tarrytown, United States of America), A. Murphy (Tarrytown, United States of America), M. Sleeman (Tarrytown, United States of America), J. Orengo (Tarrytown, United States of America). IL-33 blockade prevents exacerbations in a model of chronic airway inflammation by blunting persistent inflammation and remodeling. 3876

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
IL-33 blockade impacts mediators of persistence and exacerbation of chronic airway inflammation.
Source: International Congress 2018 – Novel drug targets for asthma and COPD
Year: 2018



Oral tolerance attenuates airway remodelling in a model of chronic allergic inflammation
Source: Eur Respir J 2006; 28: Suppl. 50, 591s
Year: 2006

Osteopontin blockade prevents fibrosis in a murine chronic model of allergic airway disease
Source: Eur Respir J 2007; 30: Suppl. 51, 60s
Year: 2007

Osteopontin deficiency protects from airway remodelling and hyperresponsiveness in chronic asthma
Source: Annual Congress 2009 - Novel mechanisms in the pathogenesis of asthma
Year: 2009


Osteopontin exacerbates airway hyperresponsiveness and lung remodeling in chronic asthma
Source: Annual Congress 2008 - Basic science in asthma and COPD
Year: 2008

Neurokinins contribute to vascular remodelling in a model of chronic pulmonary allergic inflammation
Source: Eur Respir J 2006; 28: Suppl. 50, 760s
Year: 2006

Corticosteroids prevent airway remodeling in a mouse model of chronic asthma through TGF-β signaling
Source: Eur Respir J 2006; 28: Suppl. 50, 225s
Year: 2006

Airway inflammation during stable and acutely exacerbated chronic obstructive pulmonary disease
Source: Eur Respir J 2005; 25: 640-646
Year: 2005



Effects of corticosteroid or montelukast associated to iNOS inhibition on inflammation and remodelling of distal lung in animals with chronic inflammation
Source: Annual Congress 2010 - Models of airways disease
Year: 2010


Photobiomodulation and corticosteroid modulate pulmonary inflammation and airway reactivity in an experimental model of chronic asthma
Source: International Congress 2018 – Basic pharmacology
Year: 2018

Aerobic training decreases perivascular inflammation and remodeling in a murine model of chronic allergic lung inflammation
Source: Annual Congress 2007 - Towards an understanding of asthma pathogenesis - novel in vitro assays and results from animal models
Year: 2007


Oral tolerance attenuates vascular remodelling in a model of chronic allergic inflammation
Source: Annual Congress 2010 - Animal models of asthma and lung inflammation
Year: 2010


Effect of the addition of montelukast on airway inflammation and remodeling in symptomatic asthma
Source: International Congress 2017 – Asthma: mechanisms and treatment
Year: 2017


The role of small-airway inflammation and remodeling in asthma
Source: Annual Congress 2013 –Small airways in asthma: from physiologic measures to clinical relevance
Year: 2013


MMP-9 deficiency reduces airway inflammation and hyperresponsiveness in a mouse model of asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 20s
Year: 2001

Estrogen prevents airway inflammation and hyperresponsiveness in a murine model of acute allergic asthma
Source: Eur Respir J 2007; 30: Suppl. 51, 360s
Year: 2007

Effects of N-acetylcysteine on airway inflammation, airway hyperresponsiveness and abnormal lung function in chronic ozone-induced COPD model
Source: Annual Congress 2012 - Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD
Year: 2012

Regular and moderate exercise prevents airway remodeling in a murine model of chronic allergic asthma
Source: Annual Congress 2011 - Physiological basis of respiratory disease
Year: 2011

Effects of OVA-induced allergic airway inflammation and remodeling in mice in three distinct asthma models
Source: Annual Congress 2010 - Animal models of asthma and lung inflammation
Year: 2010


Role of neutrophils in airway inflammation in children with severe persistent asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 142s
Year: 2002